Cargando…

Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis

BACKGROUND: Previous health economic studies recommend either a dual screening strategy [tuberculin skin test (TST) followed by interferon-γ-release assay (IGRA)] or a single one [IGRA only] for latent tuberculosis infection (LTBI), the former largely based on claims that it is more cost-effective....

Descripción completa

Detalles Bibliográficos
Autores principales:	Pooran, Anil, Booth, Helen, Miller, Robert F, Scott, Geoff, Badri, Motasim, Huggett, Jim F, Rook, Graham, Zumla, Alimuddin, Dheda, Keertan
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837635/ https://www.ncbi.nlm.nih.gov/pubmed/20170555 http://dx.doi.org/10.1186/1471-2466-10-7

Ejemplares similares

The pathogen recognition sensor, NOD2, is variably expressed in patients with pulmonary tuberculosis
por: Lala, Sanjay, et al.
Publicado: (2007)

What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?
por: Pooran, Anil, et al.
Publicado: (2013)

Latent Tuberculosis Infection–associated Immunodiagnostic Test Responses as Biomarkers of Incipient Tuberculosis: Fruitful or Futile?
por: Dheda, Keertan, et al.
Publicado: (2020)

The Frequency and Effect of Granulocytic Myeloid-Derived Suppressor Cells on Mycobacterial Survival in Patients With Tuberculosis: A Preliminary Report
por: Davids, Malika, et al.
Publicado: (2021)

Rapid and Accurate Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert MTB/RIF Assay—A Clinical Validation Study
por: Rachow, Andrea, et al.
Publicado: (2011)

Clinical Diagnostic Utility of IP-10 and LAM Antigen Levels for the Diagnosis of Tuberculous Pleural Effusions in a High Burden Setting
por: Dheda, Keertan, et al.
Publicado: (2009)

Evaluating Latent Tuberculosis Infection Test Performance Using Latent Class Analysis in a TB and HIV Endemic Setting
por: Adams, Shahieda, et al.
Publicado: (2019)

An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag
por: Esmail, Aliasgar, et al.
Publicado: (2020)

Same-Day Tools, Including Xpert Ultra and IRISA-TB, for Rapid Diagnosis of Pleural Tuberculosis: a Prospective Observational Study
por: Meldau, Richard, et al.
Publicado: (2019)

Predictors of discordant latent tuberculosis infection test results amongst South African health care workers
por: Adams, Shahieda, et al.
Publicado: (2019)

The Injectable Contraceptive Medroxyprogesterone Acetate Attenuates Mycobacterium tuberculosis–Specific Host Immunity Through the Glucocorticoid Receptor
por: Tomasicchio, Michele, et al.
Publicado: (2019)

Feasibility and Diagnostic Utility of Antigen-Specific Interferon-γ Responses for Rapid Immunodiagnosis of Tuberculosis Using Induced Sputum
por: Cashmore, Tamaryn J., et al.
Publicado: (2010)

Clinical Utility of a Commercial LAM-ELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples
por: Dheda, Keertan, et al.
Publicado: (2010)

Monkeypox: another test for PCR
por: Huggett, Jim F, et al.
Publicado: (2022)

ICU-Associated Acinetobacter baumannii Colonisation/Infection in a High HIV-Prevalence Resource-Poor Setting
por: Ntusi, Ntobeko B. A., et al.
Publicado: (2012)

Modulation of Cell Death by M. tuberculosis as a Strategy for Pathogen Survival
por: Abebe, Markos, et al.
Publicado: (2011)

Increased Production of IL-4 and IL-12p40 from Bronchoalveolar Lavage Cells Are Biomarkers of Mycobacterium tuberculosis in the Sputum
por: Nolan, Anna, et al.
Publicado: (2013)

What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
por: Sharma, Surendra K., et al.
Publicado: (2019)

Tuberculosis — An Epidemic of Injustice
por: Grange, John, et al.
Publicado: (1997)

Persistently elevated T cell interferon-γ responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report
por: Pai, Madhukar, et al.
Publicado: (2006)

Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection
por: Gina, Phindile, et al.
Publicado: (2017)

Childhood Tuberculosis and Infection with the Human Immunodeficiency Virus
por: Chintu, Chifumbe, et al.
Publicado: (1995)

Diagnosing tuberculosis in hospitalized HIV-infected individuals who cannot produce sputum: is urine lipoarabinomannan testing the answer?
por: Sabur, Natasha F., et al.
Publicado: (2017)

Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa
por: Shean, Karen, et al.
Publicado: (2013)

Delamanid expanded access novel treatment of drug resistant tuberculosis
por: Rustomjee, Roxana, et al.
Publicado: (2015)

Differential susceptibility of PCR reactions to inhibitors: an important and unrecognised phenomenon
por: Huggett, Jim F, et al.
Publicado: (2008)

Correction: Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa
por: Shean, Karen, et al.
Publicado: (2013)

Vitamin D as Adjunctive Host-Directed Therapy in Tuberculosis: A Systematic Review
por: Wallis, Robert S., et al.
Publicado: (2016)

Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe
por: Zijenah, Lynn Sodai, et al.
Publicado: (2016)

Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants
por: Zumla, Alimuddin, et al.
Publicado: (2018)

Phage display of functional αβ single-chain T-cell receptor molecules specific for CD1b:Ac(2)SGL complexes from Mycobacterium tuberculosis-infected cells
por: Camacho, Frank, et al.
Publicado: (2013)

Can Point-of-Care Urine LAM Strip Testing for Tuberculosis Add Value to Clinical Decision Making in Hospitalised HIV-Infected Persons?
por: Peter, Jonathan G., et al.
Publicado: (2013)

Diagnosis of COVID-19: Considerations, Controversies and Challenges in South Africa
por: Dheda, Keertan, et al.
Publicado: (2020)

Tuberculosis control is crucial to achieve the MDGs
por: Atun, Rifat, et al.
Publicado: (2010)

Performance of Serum C-Reactive Protein as a Screening Test for Smear-Negative Tuberculosis in an Ambulatory High HIV Prevalence Population
por: Wilson, Douglas, et al.
Publicado: (2011)

Tuberculosis drug discovery in the post-post-genomic era
por: Lechartier, Benoit, et al.
Publicado: (2014)

Comparison of a Clinical Prediction Rule and a LAM Antigen-Detection Assay for the Rapid Diagnosis of TBM in a High HIV Prevalence Setting
por: Patel, Vinod B., et al.
Publicado: (2010)

Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa
por: Pietersen, Elize, et al.
Publicado: (2023)

Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
por: Zumla, Alimuddin, et al.
Publicado: (2016)

Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
por: Metcalfe, John, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ivnqn9v8ebv7p18p8kehtdspif